Tumour Size and Overall Survival in a Cohort of Patients with Unifocal Glioblastoma: A Uni- and Multivariable Prognostic Modelling and Resampling Study.

brain neoplasms diagnostic imaging glioblastoma prognosis survival analysis tumour volume

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
27 Mar 2024
Historique:
received: 15 02 2024
revised: 15 03 2024
accepted: 20 03 2024
medline: 13 4 2024
pubmed: 13 4 2024
entrez: 13 4 2024
Statut: epublish

Résumé

Published models inconsistently associate glioblastoma size with overall survival (OS). This study aimed to investigate the prognostic effect of tumour size in a large cohort of patients diagnosed with GBM and interrogate how sample size and non-linear transformations may impact on the likelihood of finding a prognostic effect. In total, 279 patients with a IDH-wildtype unifocal WHO grade 4 GBM between 2014 and 2020 from a retrospective cohort were included. Uni-/multivariable association between core volume, whole volume (CV and WV), and diameter with OS was assessed with (1) Cox proportional hazard models +/- log transformation and (2) resampling with 1,000,000 repetitions and varying sample size to identify the percentage of models, which showed a significant effect of tumour size. Models adjusted for operation type and a diameter model adjusted for all clinical variables remained significant (

Identifiants

pubmed: 38610979
pii: cancers16071301
doi: 10.3390/cancers16071301
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Kavi Fatania (K)

Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, Leeds LS1 3EX, UK.
Leeds Institute of Medical Research, University of Leeds, Leeds LS2 9TJ, UK.

Russell Frood (R)

Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, Leeds LS1 3EX, UK.
Leeds Institute of Medical Research, University of Leeds, Leeds LS2 9TJ, UK.

Hitesh Mistry (H)

Division of Cancer Sciences, The University of Manchester, Manchester M13 9PL, UK.

Susan C Short (SC)

Leeds Institute of Medical Research, University of Leeds, Leeds LS2 9TJ, UK.
Department of Oncology, Leeds Teaching Hospitals NHS Trust, St James's University Hospital, Leeds LS9 7TF, UK.

James O'Connor (J)

Division of Cancer Sciences, The University of Manchester, Manchester M13 9PL, UK.
Department of Radiology, The Christie Hospital, Manchester M20 4BX, UK.
Division of Radiotherapy and Imaging, Institute of Cancer Research, London SM2 5NG, UK.

Andrew F Scarsbrook (AF)

Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, Leeds LS1 3EX, UK.
Leeds Institute of Medical Research, University of Leeds, Leeds LS2 9TJ, UK.

Stuart Currie (S)

Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, Leeds LS1 3EX, UK.
Leeds Institute of Medical Research, University of Leeds, Leeds LS2 9TJ, UK.

Classifications MeSH